Department
of Public
Health
University of Helsinki,
Finland
harri.hemila@helsinki.fi
https://www.mv.helsinki.fi/home/hemila
Sept 21, 2021
Louhiala P, Hemilä H.
Can CAM treatments be
evidence-based?
Focus on Alternative and Complementary
Therapies 2014;19(2):84-89
https://doi.org/10.1111/fct.12110
https://helda.helsinki.fi/handle/10138/228056
https://www.mv.helsinki.fi/home/hemila/H/HH_2014_FACT.pdf
Hemilä H.
Alternative Medicine is a Useful
Concept.
Medical Humanities [e-Letter Nov 6,
2017]
https://mh.bmj.com/content/36/2/115.responses
https://helda.helsinki.fi/handle/10138/228055
(2010 version of comments)
Hemilä H.
Djulbegovic and Guyatt do not refute my criticism of
their 3 novel EBM principles
https://www.ncbi.nlm.nih.gov/pubmed/28215660#cm28215660_77821
Hemilä H.
The three novel principles for EBM are old: the emperor has no clothes
https://www.ncbi.nlm.nih.gov/pubmed/28215660#cm28215660_74734
Hemilä H.
Limitations of randomized trials: problems in the
“evidence” of EBM
Placebo: Placebo effects in
musculoskeletal disorders. [Meeting paper]
13th Physiatric
Summer School, 16-17.8.2012, Helsinki
https://www.mv.helsinki.fi/home/hemila/H/HH_2013_Orton.pdf
Hemilä H.
Vitamin C, the placebo effect, and the common
cold:
a case study of how preconceptions influence the
analysis of results.
Journal of Clinical Epidemiology
1996;49(10):1079-1084
https://doi.org/10.1016/0895-4356(96)00189-8
https://hdl.handle.net/10250/8082
https://www.mv.helsinki.fi/home/hemila/H/HH_1996_JCE.pdf
Discussion JCE 1996;49:1085-1087
Chalmers: To the preceding article by H. Hemilä
https://doi.org/10.1016/0895-4356(96)00190-4
Hemilä H: Response to the dissent by
Thomas
Chalmers.
https://doi.org/10.1016/0895-4356(96)00191-6
https://hdl.handle.net/10250/8079
https://www.mv.helsinki.fi/home/hemila/H/HH_1996_JCE2.pdf
Hemilä
H. Citation bias in the CONSORT comments on blinding.
BMJ
[e-Letter 18 May 2010]
https://www.bmj.com/rapid-response/2011/11/02/citation-bias-consort-comments-blinding
Hemilä H. Assessment of the importance of
double-blinding should be based on systematic reviews:
rebuttal.
Journal of Thrombosis and Haemostasis
2008;6(7):1247-1248
https://doi.org/10.1111/j.1538-7836.2008.03006.x
https://hdl.handle.net/10138/25297
Hemilä H. RE: “Bias in clinical intervention
research”.
American Journal of Epidemiology
2007;165(10):1219
https://doi.org/10.1093/aje/kwm081
Hemilä H. The author replies
[to a
commentary on “Bias in clinical intervention research”].
American Journal of Epidemiology 2008;167(4):501-502
https://doi.org/10.1093/aje/kwm374
(Reply to: https://doi.org/10.1093/aje/kwm372)
Hemilä
H. Analysis of clinical data with breached blindness.
Statistics
in Medicine 2006;25(8):1434-1437
https://doi.org/10.1002/sim.2347
https://www.mv.helsinki.fi/home/hemila/H/2006_L_SIM.pdf
https://helda.helsinki.fi/handle/10138/228098
Hemilä H. Echinacea, vitamin C, the
common cold, and blinding.
Clinical Infectious Diseases
2005;41(5):762-763
https://doi.org/10.1086/432629
Hemilä H. Allocation concealment and blinding:
when ignorance is bliss.
Medical Journal of Australia
2005;183(4):165-166
https://www.mja.com.au/journal/2005/183/3/allocation-concealment-and-blinding-when-ignorance-bliss-0
https://www.mv.helsinki.fi/home/hemila/H/2005_L_MJA_2p.pdf
Hemilä H. Assessment of blinding may be
inappropriate after the trial.
Contemporary Clinical Trials
2005;26(4):513-515
https://doi.org/10.1016/j.cct.2005.04.002
https://hdl.handle.net/10250/7981